Ideagen Share Discussion Threads

[igoe104] 09/8/2017 19:29

Some massive trades have gone in after the bell.

10,981,737 were traded today.

[igoe104] 09/8/2017 16:23

buys coming in at 82p now, hopefully the downward momentum is going to change.

[superadams] 09/8/2017 09:37

Also been buying more at these levels. This co ticks all the right boxes for me.

[igoe104] 09/8/2017 09:28

Just join you gents, with 25700 buy.

The companies long term ambitions, got my juices going.

so I had to take advantage of the retrace.

[fizzypop] 09/8/2017 08:13

Seems an excellent buy opportunity in a top-quality company so topped up with another 5000sh @ 80.7p.

[martinthebrave] 08/8/2017 13:32

How can shortfalls in quality threaten to land utility companies in hot water?

[superadams] 08/8/2017 11:42

Riv, this is on my top up list when I eventually cash Paysafe in.

[rivaldo] 08/8/2017 11:39

Another award for IDEA:



"Chelmsford City Council’s Ideagen EasySite website named ‘Best in the UK’ at SOCITM Awards
07 August 2017

Chelmsford City Council’s website, built using Ideagen’s EasySite content management system, has been named the UK’s best for a Local Authority at a recent awards ceremony.

The SOCITM ‘Better Connected Awards’ recognises the strongest websites from Councils across Britain following months of surveys on each aspect of a local authority’s site.

A total of fifty councils were nominated to attend the awards ceremony, split into various categories including Best Council, Best for Mobile and Best Accessibility.

Chelmsford City’s EasySite website saw them nominated in four categories – more than any other local authority.

The strength of the site resulted in them eventually winning three awards - 'Best Council - Council Tax'; 'Best Council - Accessibility'; and 'Best Council - Shire District' as well as being named 'Best Council - Overall' in the UK.

Jonathan Lagden, Customer Service Development Officer at Chelmsford City Council, said the Council’s website also received 4 SOCITM stars – the highest level available.

etc"

[bamboo2] 07/8/2017 09:45

There must be a very determined seller around. Chart could be on the point of confirming a H&S with a tp approx 72. The neckline is, however, also a trendline that should offer some support.

[rivaldo] 04/8/2017 13:59

Nice:



"Ideagen PleaseReview wins ‘Best Document Review Solutions Provider’ at International Life Science Awards
03 August 2017

Ideagen PleaseReview, Ideagen’s document review, co-authoring and redaction software, has won ‘Best Document Review Solutions Provider’ at the International Life Science Awards 2017.

PleaseReview is a specialist software solution that makes it easy for teams to work together to deliver high-quality documents. Going beyond simply sharing files – it has the unique ability to control collaboration within the document.

Now in its second year, the International Life Sciences Awards 2017 endeavour to reward and recognise shining stars in the life sciences sector – from established and successful organisations to smaller niche enterprises making their mark on the industry.

Pharmaceutical, Biotech and other Life Science businesses operate in an extremely document-intensive, highly regulated environment. PleaseReview supports this critical process of producing compliant, quality documents within tight deadlines.

David Hornsby, Ideagen CEO, said: “Bringing products to market is a huge task, so implementing efficiency improvements is essential.

“To collaboratively edit and review complex documents generated for clinical trials, quality assurance and regulatory submissions, which often require the contribution from various functional area authors and subject matter experts to an organisation, requires specialist technology capabilities. It is why PleaseReview is used by many of the world’s leading pharmaceutical companies.”

David added: “We know from our customers how valuable PleaseReview is to their businesses. Recognition from industry peers is a testament to the strength and quality of the product and marks the beginning of another exciting 12 months for PleaseReview.”

PleaseReview, which became part of Ideagen’s product suite following its acquisition of PleaseTech in March this year, is used by over 180 organisations worldwide including 70% of the leading pharmaceutical biotech organisations.

The software provides simultaneous, controlled and secure collaboration for review, co-authoring and redaction resulting in faster document development and enhanced quality. Reporting and metrics ensure transparency, accountability and facilitate process improvements."

[grabster] 02/8/2017 14:52

Nice one. Especially if it appears in authority mags nationwide as an example to others.

EDIT:

(Horsham in the middle of page)

[fizzypop] 31/7/2017 08:35

Thx rivaldo.

"Turnover was up 24 percent from £21.9m to £27.1m for the year ending April 2017, while profit also rose by 24 percent from £6.3m to £7.8m. Next year, revenue and profit are expected to hit £34m and £11m respectively."

So forecast revenue up 25% and profit up 41% for next year.

[rivaldo] 30/7/2017 07:13

Terrific new article about IDEA - much too long to copy, but here's some extracts::



"The software developer that wants to become Nottingham's next major firm alongside Boots, Experian and Capital One"

"As CEO David Hornsby points out several times, there won’t be many businesses in the county that have rocketed in value on the stock market from £1m to £170m in less than a decade.

But that’s what his Ruddington-based business has done through both organic and acquisition-led growth.

The path is clear for plenty more expansion, too, for a company that counts organisations like Heineken, the NHS and British Airways among its clients.

Operating in a world where governance compliance becomes more prevalent by the minute, there will always be scope for more opportunities for Ideagen, which makes quality, safety, audit, performance and risk management software.

Dave says: “Experian is a giant of the industry but in 20 years’ time, Ideagen will be up there with it.”

"AIM-listed Ideagen, which is currently on the lookout for 50 new staff, has increased revenue at a rapid pace.

Turnover was up 24 percent from £21.9m to £27.1m for the year ending April 2017, while profit also rose by 24 percent from £6.3m to £7.8m. Next year, revenue and profit are expected to hit £34m and £11m respectively.

Exports make up about half the business, with a prestigious list of clients both home and abroad.

David points out that Ideagen supplies its information management programmes to eight of the top 10 accountancy firms in the UK, seven of the top 10 global aerospace and defence companies, 17 of the world’s top 25 pharmaceutical firms, and 80 percent of the UK’s NHS trusts.

BAE Systems uses its software for compliance and risk management on its Eurofighter Typhoon model; Heineken and Shell’s internal audits are controlled by Ideagen programmes; and the Rail Safety and Standards Board (RSSB) uses it for risk management across the entire rail industry, logging 70,000 incidents a year and analysing the data to help prevent recurrences."

"Other elite names among Ideagen’s client list include Airbus, British Airways, Emirates and the European Central Bank.

While the company’s expansion has be largely explained by a series of acquisitions, there has also been organic growth helped by the market it operates in.

Legislation for complex, highly-regulated businesses is always changing, meaning organisations must have the right systems and procedures in place to make sure they are compliant.

Barnaby says: “There’s more and more companies around the world, in pretty much every sector, where risk has a greater emphasis."

"One of the most recent examples of this is the General Data Protection Regulation, which comes into force next year to address the increasingly complex cyber security threat that came to light most prominently in the global cyber-attack that crippled the NHS in May.

Data has already proven to be an invaluable asset in the industry – in what Barnaby calls “evidence based risk management” – in improving flight safety."

"In order to keep up with the changing landscape, Ideagen employs a third of its staff in research and development to bring new software to the market, as well as two ethical hackers whose job is to break into systems so they can identify vulnerabilities and respond.

The company also has one eye on competitors in a bid to stay ahead of the game.

David adds: “About 50 percent of the marketplace doesn’t have specific systems to manage risk management."

"“They have spreadsheets and word documents – manual systems – and these are big companies.

“If you said that 50 percent of the world didn’t have an accounting system, it would be crazy.

“But everyone has to get tooled up and that’s our job to help them.”"

[speedsgh] 28/7/2017 16:23

£202k sale by COO to part fund a property purchase...

Director Dealing -

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that today Barney Kent, Chief Operating Officer of the Company, sold 245,000 ordinary shares of 1 pence each ("Ordinary Shares") at a price of 82.5 pence per Ordinary Share to part fund a property purchase (the "Sale").

Following the Sale, Mr. Kent's beneficial interest in the Company is 1,772,660 Ordinary Shares representing approximately 0.89% of the issued share capital of the Company.

[rivaldo] 27/7/2017 09:52

FYI I came across this interview with the CEO with some encouraging comments:



Extract:

"Hornsby also said that Ideagen had not seen any downturn in its business as a result of the Brexit vote, thanks to its broad client base and geographic spread.

He added: “Governance, risk and compliance is across many different industries, and some need it more than others, so we focus on those that are highly regulated, such as life sciences, financial services, aerospace and defence. These organisations have to invest in risk management and compliance, because it’s demanded of them by the regulators.”

Aim-quoted Ideagen, which has a total workforce of more than 360, made four acquisitions during year, including the £3.6m purchase of GRC outfit Covalent Software, and Hornsby said that the group would be seeking further deals along with pursuing organic growth, which came in at 10 per cent in the year to April.

“What the market doesn’t like is if you make acquisitions and then don’t create any further value, and the way we do that is by growing the businesses we buy and striking a pretty good deal – we try to pay the lowest amount possible, as you would expect,” he added.....

...Analysts at house broker FinnCap said: “Ideagen management’s tried and tested methodology continues to deliver.”

[rivaldo] 24/7/2017 10:48

Finncap note in reiterating their 108p target price that results were ahead of expectations on all the main metrics:

"Consistent strength in delivery

Typically impressive prelims are in line with the May trading, pleasantly ahead of prior forecasts: EBITDA of £7.9m (£7.8mE); revenue of £27.1m (£26.2mE); net cash of £4.2m (vs £1.6mE) strong even after adjusting for an abnormal creditor of £0.8m. The year delivered 10% organic growth, enhanced by benefit of four acquisitions in the period, and supported by an oversubscribed £10m placing at 75p, a premium to the then shareprice.

Ideagen management’s tried and tested methodology continues to deliver, evidenced by relentless execution at or ahead of forecasts; adding new customers and retaining existing customers; stable margins and increasing cash generation; and increasing visibility through a growing recurring revenue base. Target price 108p reiterated, with unmodelled inevitable acquisitions expected to continue to add to the strong core.

Results in line with the May trading update, with continuing improvement in earnings quality through the increase in recurring revenue (£15.5m, up from £11.4m) equivalent to 57% (54%) of group revenue. Recurring revenue growth is driven by the rising base of SaaS revenue (£4,8m), adding to the ongoing
maintenance and support from previous, and current, licence sales, given the hybrid model. We push up FY17 revenue expectations +3%, EBITDA unchanged; with net cash expectations lifted to £7.0m (formerly £5.6mE).

Group organic revenue growth of 10%, (including proforma performance by the four businesses acquired during the period), was derived principally from 13% organic growth within the core GRC business, representing 84% of group revenue. Revenue growth was accompanied by margin growth, with both gross margin of 89.5% (FY16: 88%) and EBITDA of 29% (28.5%) highlighting consistent expansion, which we expect to continue. Customer growth in the period is encouraging, especially given the strong account management focus to ensure a 97% (FY16: 96%) renewal rate.

The board appointments of the Chief Operating Officer and Chief Customer Officer highlight the depth in senior management evident at the June capital markets day, with a further NED appointment expected. The momentum for Ideagen is evident, and we expect the tried and tested formula to continue to generate healthy returns. Target price 108p reiterated."

[rivaldo] 20/7/2017 10:08

Newly tipped in the IC as follows:

"Management at Ideagen (IDEA) were keen to emphasise the value-add from acquisitions made over the full year to 30 April 2017 – not just buying companies for the sake of it, but finding ways to integrate new businesses in a way that enhances their current offering. Revenues for the IT software specialist grew by almost a quarter during the period, which included underlying organic growth of 10 per cent, suggesting that it is not simply inflating its top line via acquisition. But the costs of the strategy meant operating profit fell 30 per cent to £0.7m.

In an attempt to boost recurring revenue, Ideagen is increasingly moving from a licencing model towards a subscription-based model. Progress has already been made, with recurring revenues comprising 57 per cent of Ideagen’s total, up from 54 per cent last year. Management expects that this could reach 70 per cent in the medium term.

The four acquisitions made in the period were intended to add intellectual property and recurring revenue, as well as vertical integration; with one such example being Covalent – purchased to add a risk management element to Ideagen’s audit management offering Pentana.

Analysts at FinnCap expect £9.7m of pre-tax profit in the year to April 2018, giving EPS of 4.2p, compared with £6.9m and 3.2p in FY2017.

IDEAGEN (IDEA)
ORD PRICE: 83.5p MARKET VALUE: £ 165m
TOUCH: 83.0-84.0p 12-MONTH HIGH: 98p LOW: 52p
DIVIDEND YIELD: 0.3% PE RATIO: 209
NET ASSET VALUE: 23.4p* NET CASH £4.2m

IC View

Ideagen has proved that it grow organically and by acquisition. Shares aren't cheap at 20 times forward earnings, falling to 18 times in FY2018. But there's net cash on the balance sheet and good forecast top-line growth. Buy."

[rivaldo] 19/7/2017 07:20

Nice tip for IDEA here:



"Ideagen(LSE: IDEA), a leading supplier of Information Management software, revealed a surge in annual profits earlier today as it announced its full-year results for FY2017. The AIM-listed technology business reported another strong performance for the year to 30 April. It was its eighth consecutive year of sales and earnings growth, with total revenues coming in 24% higher at £27.1m, and adjusted pre-tax profits rising to £6.9m, from £5.7m just a year ago.

Fourfold increase

The Nottingham-based firm provides quality, safety, audit, performance and risk-management software and expertise and has operations in the UK, EU, US, and the Middle East. With an excellent portfolio of software products, it helps companies to improve operational efficiency, strengthen compliance, and anticipate and manage every detail of risk, helping to reduce costs and improve efficiency.

With a market value of £166m the AIM-listed group may be considered small-fry when compared to software giants such as Sage Group, valued at £7.2bn, but it can still boast a customer base of over 3,000 organisations that use its products. These include many blue chip names such as BAE Systems, Emirates Airlines, Royal Dutch Shell and the European Central Bank, as well as 180 hospitals in the UK and US.

Despite a fourfold increase in the share price over the last five years, the shares have never breached the £1 mark, but I think this is about to change. With City analysts forecasting a further 28% improvement in underlying earnings for the current year to April, investors should look past the premium P/E rating of 21 and see that this is a price well worth paying for rapid growth."

[bamboo2] 18/7/2017 22:30

INVH&S tp 92-94.5

[glasshalfull] 18/7/2017 19:08

Thanks for updates rivaldo.

Well done (yet again) to DH & staff for delivering an 8th year of earnings growth. Not many companies can claim such a consistent record.

Posted this on Twitter...click on the photo highlights the earnings progression.



Regards
GHF

[rivaldo] 18/7/2017 11:25

Finncap retain their 108p target.

And Techmarketview love the company :o))



"Tuesday 18 July 2017

Confident Ideagen: organic growth alongside buy-and-build strategy

With four acquisitions completed (start the trail here), following a year of abstinence, Ideagen has changed shape but achieved the outcomes it planned for, as revenue for the year to April 30 2017 rose 24% to £27.1m and it met or exceeded key financial and operational objectives.

The information management provider who targets regulated industries, is back to pursuing a strategy of buy and build but importantly says it is committed to achieving organic growth too. Indeed it achieved a more than respectable 10% organic growth, the same as in the previous year. The bottom line moved upwards too with adjusted EBITDA up 26% to £6.9m and adjusted PBT of £6.9m, a 22% increase.

GRC is the growth engine - and 84% of revenue - and where Ideagen is building scale. The aviation, life sciences, financial services sectors performed well over the year, more than making up for the clinical medical solutions sector which was hit by NHS Trust funding uncertainty. What was particularly reassuring was the growth in SaaS revenue - up 133%, taking it to £4.8m. Operationally it attracted new customers (150 on-premise, 45 SaaS) while also securing extensions with existing customers such as Jaguar Land Rover, DHL and BDO. Management is in a confident mood and GRC is a growth market. "

[pj 1] 18/7/2017 08:14

Unless there is a holding RNS we will never know for sure. Hopefully it was a Sell and confirms the recent Seller has perhaps cleared.


IMO

[petewy] 18/7/2017 08:07

Big buy just went thru 170,000+ Hope it was a buy???
Can't find the dividend rise.

[cheshire man] 18/7/2017 07:43

Well pleased with FR from IDEA :-)